Brought to you by 
Bristol-Myers Squibb buys DuPont Pharma for $7.8bn
18 Dec 2001
Executive Summary
In another move to focus more on its medicines business, Bristol-Myers Squibb won the bid (over Bayer, a close contender) to acquire DuPont Pharmaceuticals for $7.8bn in cash. The transaction is expected to close by the end of the year.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Bristol-Myers Squibb buys DuPont Pharma for $7.8bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice